Alzheimer’s disease

A leukemia drug know as Nilotinib that is already on the market might also be able to treat the hallmark signs of Parkinson’s disease. This break through study represents the first time a therapy appears to reverse cognitive and motor decline in patients with Parkinson’s disease, according to the researchers.

Currently undergoing clinical trials, the drug saracatinib, which was originally developed for cancer, is being repurposed as a treatment for Alzheimer’s. Animal testing at the Yale University School of Medicine showed a decrease in memory loss and reversal of brain damage caused by the mouse model of the disease. After obtaining the drug from AstraZeneca, researchers were able […]